LabConnect Launches Data Integration Services
Seattle, WA. - LabConnect, a leading provider of highly customized global central laboratory and early development services to biopharmaceutical, medical device and contract research organizations, has announced the launch of its data integration services, which help sponsors coordinate complex, high-volume data collection and management from multiple laboratories’ data sources.
LabConnect’s enhanced, comprehensive data management capabilities streamline clinical trials by developing an infrastructure and coordinating logistics for programming, coding, cleaning and conditioning data that comes from a variety of sources.
By mapping and assembling the disparate data sources, standardizing data formats and merging, LabConnect provides superior data consistency, accuracy and usability. These outsourced solutions save sponsor resources and are particularly useful for delivering cohesive data for clinical projects, especially where timelines can be challenging.
“LabConnect’s robust data management services and tools provide sponsors improved speed, quality and continuity in their data,” said Eric Hayashi, president and CEO. “Data quality is ensured and documentation approved by the sponsor. We can often provide these services to our clients at a lower cost and with a faster turnaround than they can achieve keeping the tasks in-house, allowing them to remain focused on the core objectives of their clinical innovation.”
For more information about data integration and additional service areas, visit labconnectllc.com.
About LabConnect, LLC
Founded in 2002, LabConnect provides global central laboratory services including routine and specialized laboratory testing, kit building, sample management, data management, biorepository and scientific support services for biopharmaceutical, medical device and CRO clients. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory and early development service needs, from preclinical through Phase IV. Learn more at www.labconnectllc.com or connect with LabConnect on LinkedIn.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
